Citalopram hydrobromide and Oxybutynin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Citalopram hydrobromide (citalopram hydrobromide) and Oxybutynin (oxybutynin). Common drug interactions include paralysis among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Citalopram hydrobromide and Oxybutynin. It is created by eHealthMe based on reports of 69 people who take the same drugs from the FDA, and is updated regularly.

What is Citalopram hydrobromide?

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 36,878 Citalopram hydrobromide users. Check the latest studies of Citalopram hydrobromide.

What is Oxybutynin?

Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 23,143 Oxybutynin users. Check the latest studies of Oxybutynin.



On Jul, 17, 2026

69 people who take Citalopram hydrobromide and Oxybutynin together, and have interactions are studied.

Citalopram hydrobromide and Oxybutynin drug interactions.

What are the common drug interactions of Citalopram Hydrobromide and Oxybutynin, by gender? *:

female:

  1. Paralysis
  2. Dry skin
  3. Urticaria (rash of round, red welts on the skin that itch intensely)
  4. Drug ineffective
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Alopecia (absence of hair from areas of the body)
  7. Furuncle (infection of the hair follicle)
  8. Skin discolouration (change of skin colour)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Spinal cord neoplasm (tumour of spinal cord)

male:

  1. Fall
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Pain in extremity
  5. Urinary tract infection
  6. Abdominal pain
  7. Abdominal pain upper
  8. Anaemia (lack of blood)
  9. Aortic calcification (aortic calcification sign of heart valve disease)
  10. Aortic disorder

What are the common drug interactions of Citalopram Hydrobromide and Oxybutynin, by age (0-1 to 60+)? *:

0-1:

  1. Alopecia (absence of hair from areas of the body)
  2. Cellulitis (infection under the skin)
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Drug withdrawal syndrome neonatal (prenatal nas is caused by discontinuation of drugs taken by the pregnant mother)
  5. Fall
  6. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  7. Impaired healing
  8. Infection
  9. Lymphocyte count decreased
  10. Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)

2-9:

n/a

10-19:

n/a

20-29:

  1. Autonomic nervous system imbalance (autonomic nervous system is of net equal emphasis)
  2. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  3. Therapeutic response unexpected

30-39:

  1. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)
  2. Panic attack
  3. Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)

40-49:

  1. Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
  2. Paralysis
  3. Spinal cord neoplasm (tumour of spinal cord)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Drug ineffective
  6. Neoplasm (tumour)
  7. Anaemia (lack of blood)
  8. Asthenia (weakness)
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Dizziness

50-59:

  1. Dizziness
  2. Drug intolerance (drug sensitivity)
  3. Fall
  4. Fatigue (feeling of tiredness)
  5. Functional gastrointestinal disorder (functional problem in separate organs of gastrointestinal system)
  6. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  7. Hemiparesis (weakness on one side of the body)
  8. Impaired driving ability
  9. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  10. Muscle spasticity (tight or stiff muscles and an inability to control those muscles)

60+:

  1. Fall
  2. Nausea (feeling of having an urge to vomit)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Seborrhoeic dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp)
  5. Alopecia (absence of hair from areas of the body)
  6. Dry skin
  7. Furuncle (infection of the hair follicle)
  8. Skin discolouration (change of skin colour)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Urticaria (rash of round, red welts on the skin that itch intensely)

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 14.49%
  2. Pain: 7 people, 10.14%
  3. Multiple Myeloma (cancer of the plasma cells): 7 people, 10.14%
  4. High Blood Cholesterol: 5 people, 7.25%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 5.80%
  6. Neuralgia (pain in one or more nerves): 4 people, 5.80%
  7. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 5.80%
  8. Muscle Spasms (muscle contraction): 4 people, 5.80%
  9. Gastric Disorder (disease of stomach): 4 people, 5.80%

* Approximation only. Some reports may have incomplete information.

Do you take Citalopram hydrobromide and Oxybutynin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Citalopram hydrobromide and Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Citalopram hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxybutynin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Citalopram hydrobromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxybutynin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide and oxybutynin (the active ingredients of Citalopram hydrobromide and Oxybutynin, respectively), and Citalopram hydrobromide and Oxybutynin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: